Abeona Therapeutics Inc. Common Stock
€4.905
EUR
Last updated on --.
24h volume1.06M
24h highest4.9917 EUR
24h lowest4.7380 EUR
24h Price movement+3.92%
ABEO recent prices
24 Hours
+3.92%+€0.18488
30 days
+6.25%+€0.28807
60 days
+34.63%+€1.259
90 days
+11.23%+€0.49444
Key data
Previous close4.7209 EUR
Market cap260.73M EUR
Volume1.06M
P/E ratio4.580000
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)0.99748 EUR
Net income (FY)56.87M EUR
Revenue (FY)12.50M EUR
Last report date13 May 2026
About Abeona Therapeutics Inc. Common Stock
HeadquartersCLEVELAND
Employees (FY)226.00
Revenue per employee (FY)55.32K EUR
Net income per employee (FY)251.64K EUR
Listed onNasdaq
ABEO conversion tables
 |  |
|---|---|
| 0.5 ABEO | 2.452 EUR |
| 1 ABEO | 4.905 EUR |
| 5 ABEO | 24.52 EUR |
| 10 ABEO | 49.05 EUR |
| |
|---|---|
| 0.5 EUR | 0.10192 ABEO |
| 1 EUR | 0.20384 ABEO |
| 5 EUR | 1.019 ABEO |
| 10 EUR | 2.038 ABEO |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
ABEO is trading at €4.905, +3.92% over the last 24 hours. Track live moves on the price chart at the top of this page.
The ABEO stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. ABEO is currently trading at €4.905, +3.92% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on ABEO price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. ABEO's P/E ratio is currently 4.580000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from ABEO; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against ABEO's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Abeona Therapeutics Inc. Common Stock's market cap is currently 260.73M EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume1.06M
24h highest4.9917 EUR
24h lowest4.7380 EUR
24h Price movement+3.92%
Start trade with ABEO Perpetual
Sign up to trade